Spero Therapeutics, Inc. (SPRO)

1.205 +0.06 (+5.70%) USD  |  NASDAQ  |  Oct 09, 16:00
1.20 0.00 (0.00%) After-Hours: 20:00
More

Spero Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 14, 2026 --
August 14, 2025 --
July 29, 2025 --
June 10, 2025 --
May 19, 2025 --
April 02, 2025 --
January 30, 2025 --
December 02, 2024 --
Date Value
November 18, 2024 --
November 04, 2024 --
August 06, 2024 --
August 05, 2024 --
May 16, 2024 --
May 15, 2024 --
April 04, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Kura Oncology, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade